Dubai, United Arab Emirates (CNN) — As the United States considers a future vaccination plan to combat “Covid-19”, data from three large health care systems in New York and Israel indicates that although a small percentage of people under the age of 65 receive years, a new booster dose once morest “Covid-19”, but this age group does not get very sick and does not overwhelm hospitals.
“Even if they don’t get the booster shot, healthy young people don’t get very sick from it,” said Dr. Mangala Narasimhan, senior vice president at Northwell Health Medical Center, the largest healthcare provider in New York State.
The US Food and Drug Administration has proposed a framework for annual “Covid-19” vaccines for all Americans over the age of 6 months, but has not yet come up with a concrete plan.
Vaccine advisors are scheduled to meet at the US Centers for Disease Control and Control on February 24 to discuss the future of the US “Covid-19” vaccination program.
The use of the bivalent booster dose, which has been available since last September, has been low. Nationally, only regarding 16 percent of the population has it, and rates are particularly low for people under 65, according to CDC data.
Narasimhan and doctors at Montefiore Medical Center in New York City and Clalit Health Services, Israel’s largest healthcare organization, said the relative mildness of current Covid strains, combined with a degree of immunity from vaccines and past infections, went a long way toward protecting healthy young people. Even if they don’t get the booster shots.
Dr. Ran Palliser, director of the Clalit Research Institute and head of Israel’s National Expert Advisory Group on COVID-19, pointed out that earlier in the pandemic, for example, when the Delta variant was raging, not getting vaccinated was considered a risk. Irresponsible.
Since the new booster dose became available, COVID-19 deaths among people under 65 years of age have accounted for regarding 12% of all COVID-19 deaths in the United States, according to data from the Centers for Disease Control.
A report issued by the Centers for Disease Control on Thursday analyzed death rates and vaccination status from September to December last year.
The report showed that people who received the COVID-19 vaccine, either as part of the primary vaccination series only or received an additional updated booster dose, were better protected than those who did not receive the vaccine.
The updated booster dose helps protect once morest the original strain of coronavirus and newer “Omicron” strains. It was particularly effective in reducing death rates in the elderly, compared to less efficacy for young people.
For adults younger than 65, the bivalent vaccine offered at least three times more death protection than the original vaccine, but the difference in death rates was less than one in a million.
The CDC recommends the up-to-date booster dose for everyone over 6 months of age, but a government campaign stresses the importance of getting the booster dose for people over 50.
